|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 16/28 | |
| A61K 39/395 | |||
| A61K 47/68 | |||
| A61P 35/00 |
| (11) | Number of the document | 3461847 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18204152.5 |
| Date of filing the European patent application | 2011-12-06 | |
| (97) | Date of publication of the European application | 2019-04-03 |
| (45) | Date of publication and mention of the grant of the patent | 2020-09-23 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 42029110 P | 2010-12-06 | US | |
| 201161446990 P | 2011-02-25 | US |
| (72) |
SMITH, Maria Leia, US
SUSSMAN, Django, US
ARTHUR, William, US
NESTEROVA, Albina, US
|
| (73) |
Seagen Inc.,
21823 30th Drive, S.E., Bothell, WA 98021,
US
|
| (54) | HUMANIZED ANTIBODIES TO LIV-1 AND USE OF SAME TO TREAT CANCER |
| HUMANIZED ANTIBODIES TO LIV-1 AND USE OF SAME TO TREAT CANCER |